HBI Deals+Insights / M&A/IPOs
M&A activity in healthcare has been subdued over the past two and a half years. We discussed this with Ramesh Jassal, who has just joined investment bank Heligan Group as Partner ‑ Healthcare, Corporate Finance, to build a specialist healthcare advisory team. He shared his view on why we should expect to see deal activity return in 2025, and which sub sectors will see most interest.